Avecho Biotechnology Ltd (AVE) — Capital Reinvestment Ratio

Latest as of December 2019: 0.00x

Avecho Biotechnology Ltd (AVE) has a Capital Reinvestment Ratio of 0.00x as of December 2019, meaning it reinvests 0% of its operating cash flow (AU$1.19 Million) in capital expenditures (AU$5.15K). Check Avecho Biotechnology Ltd tangible net worth ratio to evaluate the tangible quality of the company's equity base.

Capital Reinvestment Ratio

0.00x
Capex / Operating Cash Flow

Operating Cash Flow

AU$1.19 Million
AUD

Capital Expenditures

AU$5.15K
AUD

Data as of

Dec 2019
Most recent filing

Avecho Biotechnology Ltd Capital Reinvestment Ratio (2019–2019)

This chart tracks Avecho Biotechnology Ltd's Capital Reinvestment Ratio across 1 annual periods. For the full cash flow conversion analysis, see AVE cash generation efficiency.

Annual Capital Reinvestment Ratio for Avecho Biotechnology Ltd (2019–2019)

Year-by-year Capital Reinvestment Ratio for Avecho Biotechnology Ltd from 2019 to 2019. See free cash flow generation of Avecho Biotechnology Ltd to measure how efficiently the company converts operating cash flow to free cash.

Year Reinvestment Ratio Operating CF (AUD) Capital Expenditures YoY Change
2019 0.00x AU$1.19 Million AU$5.15K —
Capital Reinvestment Ratio = ABS(Capital Expenditures) / Operating Cash Flow